MedPath

3% Sodium Chloride

3% Sodium Chloride Injection, USP

Approved
Approval ID

a8058593-48af-457a-b0f0-166935c7d10c

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Jan 14, 2021

Manufacturers
FDA

Becton Dickinson and Company

DUNS: 124987988

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

3% Sodium Chloride

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code17271-703
Application NumberANDA209476
Product Classification
M
Marketing Category
C73584
G
Generic Name
3% Sodium Chloride
Product Specifications
Route of AdministrationINTRAVENOUS
Effective DateFebruary 27, 2020
FDA Product Classification

INGREDIENTS (3)

SODIUM CHLORIDEActive
Quantity: 3 g in 100 mL
Code: 451W47IQ8X
Classification: ACTIB
WATERInactive
Code: 059QF0KO0R
Classification: IACT
HYDROCHLORIC ACIDInactive
Code: QTT17582CB
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

3% Sodium Chloride - FDA Drug Approval Details